1-9 of 9
Athena Kritharis
Close
Sort by
Journal Articles

Deep DNA Sequencing Identifies Small Mutations in Patients with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Analysis of Intratumor Genomic Heterogeneity for Prediction of Disease Relapse

Athena Kritharis, MD, Sukhdeep Kaur, MD, Jui Wan Loh, BS, Mohammad Hadigol, PhD, Hossein Khiabanian, PhD, Roger Strair, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1445.
https://doi.org/10.1182/blood-2019-126303
Published: 2019
Journal Articles

Transcriptomic Systems Biology Analyses with Buparlisib (BKM120) Pan PI3K Inhibition in Canine B Cell Lymphoma (BCL): Leveraging Comparative Oncology for Cancer Therapeutics and Biomarker Discovery

Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Sarah Cass, BSVM, Athena Kritharis, MD, Kristine Burgess, DVM, MS, Cheryl London, DVM, PhD DACVIM, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 4114.
https://doi.org/10.1182/blood-2018-99-118548
Published: 2018
Journal Articles

Systemic Bevacizumab for the Treatment of Chronic Bleeding in Hereditary Hemorrhagic Telangiectasia

Hanny Al-Samkari, MD, Athena Kritharis, MD, Josanna Rodriguez-Lopez, MD, David J. Kuter, MD DPhil
Journal: Blood
Blood (2018) 132 (Supplement 1): 852.
https://doi.org/10.1182/blood-2018-99-117144
Published: 2018
Journal Articles

Gray Zone Lymphoma (GZL) with Features Intermediate between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): A Pathologic Consensus Study with Patient Outcomes and Prognostication across 15 North American Centers

Andrew M Evens, DO,MSc, Monika Pilichowska, MD PhD, Stefania Pittaluga, MD PhD, Judith Ferry, MD, Jessica Hemminger, MD, Hong Chang, PhD, Jennifer A. Kanakry, MD, Laurie H Sehn, Tatyana A Feldman, MD, Francisco J. Hernandez-Ilizaliturri, MD, Izidore S Lossos, MD, Jeremy S. Abramson, MD, Athena Kritharis, MD, Oliver W. Press, MD PhD, Timothy S. Fenske, MD, Jonathan W. Friedberg, MD, Julie M Vose, MD, Kristie A. Blum, MD, Deepa Jagadeesh, MDMPH, Bruce Woda, MD, Randy D. Gascoyne, MD, Elaine S. Jaffe, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 375.
https://doi.org/10.1182/blood.V130.Suppl_1.375.375
Published: 2017
Journal Articles

A Comparative Oncology Analysis of Canine T-Cell Lymphoma (TCL): Immunohistochemical Study and Next Generation Sequencing for Protein Analysis and Genomic Target Discovery

Athena Kritharis, MD, J. Tyson McDonald, PhD, Afshin Beheshti, PhD, Monika Pilichowska, MD, Kristine Burgess, DVM, MS, Luisel Ricks-Santi, PhD, Elizabeth McNiel, DVM, PhD, Ravi Dashnamoorthy, PhD, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2015) 126 (23): 3883.
https://doi.org/10.1182/blood.V126.23.3883.3883
Published: 2015
Journal Articles

Improvements in Patient Outcomes with Autologous Stem Cell Transplantation for Multiple Myeloma over 25 Years at a Single Center

Sandy W. Wong, MD, Melissa Warner, BS, Alejandro Moreno-Koehler, MPH, Athena Kritharis, MD, Michael E Coyle, MD, Deborah Black, RN, BSN, Valerie Relias, PharmD, BCOP, Terry Fogaren, RN, BSN, Nancy Cody Lyons, NP, Francois Toka, NP-C, Denise Larivee, RN, Hedy Smith, MD PhD, Andrew M. Evens, DO, MSc, Grace Kao, MD, Kellie Sprague, MD, Andreas K. Klein, MD, Kenneth B. Miller, MD, Raymond L. Comenzo, MD
Journal: Blood
Blood (2015) 126 (23): 5496.
https://doi.org/10.1182/blood.V126.23.5496.5496
Published: 2015
Journal Articles

Lenalidomide in non-Hodgkin lymphoma: biological perspectives and therapeutic opportunities

Clinical Trials & Observations
Athena Kritharis, Michael Coyle, Jaya Sharma, Andrew M. Evens
Journal: Blood
Blood (2015) 125 (16): 2471–2476.
https://doi.org/10.1182/blood-2014-11-567792
Published: 2015
Includes: Supplemental data
Journal Articles

A Comparative Oncology Study of Canine and Human Genomics and Proteomics in Peripheral T-Cell Lymphoma (PTCL): Examination of Shared Oncogenic Signaling for Biomarker and Therapeutic Target Discovery

Athena Kritharis, MD, Trent Fowler, PhD, Ravi Dashnamoorthy, PhD, Kristine E Burgess, DVM, MS, Afshin Beheshti, PhD, Nassera Abermil, MS, PharmD, Ananda Roy, PhD, Lynn Hlatky, PhD, Monika Pilichowska, MD, Elizabeth McNiel, DVM, PhD, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2014) 124 (21): 3019.
https://doi.org/10.1182/blood.V124.21.3019.3019
Published: 2014
Journal Articles

Gray Zone Lymphoma (GZL) with Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of Tumor Immunophenotype (IP) and Critical Examination of Therapy with Associated Impact on Outcome

Athena Kritharis, MD, Jennifer A. Kanakry, Laurie H. Sehn, MDMPH, Tatyana Feldman, MD, Aimee Kroll, MS, Randy D. Gascoyne, MD, Adam M. Petrich, MD, Jeremy S. Abramson, MD, Francisco Hernandez-Ilizaliturri, MD, Zeina Al-Mansour, MD, Camille Adeimy, MD, Jessica Hemminger, MD, Nancy L. Bartlett, MD, Anthony R. Mato, MD, Paolo Caimi, MD, Ranjana Advani, MD, Andreas K. Klein, MD, Izidore S Lossos, MD, Oliver W. Press, MD PhD, Sonali M. Smith, MD, Jesus C Fabregas, MD, Chadi Nabhan, MD FACP, Timothy S. Fenske, MD, Jonathan W. Friedberg, MD, Julie M. Vose, MD MBA, Kristie A. Blum, MD, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2014) 124 (21): 1703.
https://doi.org/10.1182/blood.V124.21.1703.1703
Published: 2014